Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Hemodialysis Catheter Complications in the Emergency Department Versus Hemodialysis Unit

9 giugno 2026 aggiornato da: Antalya Health Sciences University

Comparison of the Risk of Catheter Thrombosis and Catheter-Related Infection Between Patients Undergoing Hemodialysis Catheter Insertion in the Emergency Department and Those Undergoing Catheter Insertion in the Hemodialysis Unit: A Prospective Observational Study

This prospective observational cohort study was designed to compare the risk of catheter thrombosis and catheter-related infection between adult patients who underwent temporary hemodialysis catheter insertion in the emergency department and those who underwent catheter insertion in the hemodialysis unit.

The study was conducted at Antalya Training and Research Hospital. Adult patients aged 18 years and older who underwent hemodialysis catheter insertion in either the emergency department or the nephrology hemodialysis unit were included. A total of 398 patients were enrolled between December 1, 2024, and December 1, 2025. Demographic and clinical data were collected, and catheter-related complications occurring within 10 days after catheter insertion were assessed using hospital records and follow-up data.

Panoramica dello studio

Descrizione dettagliata

Hemodialysis catheters are frequently used as temporary vascular access in patients requiring urgent or ongoing hemodialysis. Although these catheters provide rapid access for dialysis, catheter-related complications such as thrombosis and infection may result in catheter dysfunction, interruption of dialysis, repeated catheter placement, increased morbidity, and additional healthcare burden.

In emergency departments, temporary hemodialysis catheters are often inserted under urgent clinical conditions. Although standard aseptic and antiseptic measures are applied, factors such as limited preparation time, clinical instability of the patient, and the need for rapid dialysis may affect the risk of catheter-related complications. In contrast, catheter insertion in a hemodialysis unit is generally performed in a more controlled clinical environment.

This prospective observational cohort study compared two groups of adult patients: those who underwent temporary hemodialysis catheter insertion in the emergency department and those who underwent catheter insertion in the nephrology hemodialysis unit. The primary focus was to evaluate whether the catheter insertion setting was associated with differences in the development of catheter thrombosis and catheter-related infection within ten days after catheter placement.

The study included 398 adult patients treated at Antalya Training and Research Hospital between December 1, 2024, and December 1, 2025. Demographic and clinical data were collected, and complications occurring within ten days after catheter insertion were assessed using hospital records and follow-up data. The findings of this study may help determine whether additional preventive measures are needed for hemodialysis catheter insertion procedures performed in emergency department settings.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

398

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • konyaaltı
      • Antalya, konyaaltı, Turchia (Türkiye), 07100
        • University of Health Sciences, Antalya Training and Research Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population consisted of adult patients aged 18 years and older who underwent temporary hemodialysis catheter insertion in either the emergency department or the nephrology hemodialysis unit at Antalya Training and Research Hospital between December 1, 2024, and December 1, 2025. Participants were followed for 10 days after catheter insertion to evaluate the development of catheter thrombosis and catheter-related infection.

Descrizione

Inclusion Criteria:

  • Patients aged 18 years or older
  • Patients who underwent temporary hemodialysis catheter insertion in the emergency department
  • Patients who underwent temporary hemodialysis catheter insertion in the hemodialysis unit
  • Patients who agreed to participate in the study

Exclusion Criteria:

  • Patients younger than 18 years of age
  • Patients who did not agree to participate in the study
  • Patients with known platelet function disorder
  • Patients with hematologic diseases, including malignancy
  • Immunosuppressed patients

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Emergency Department Hemodialysis Catheter Group
Adult patients who underwent temporary hemodialysis catheter insertion in the emergency department. Participants were followed for 10 days after catheter insertion to assess the development of catheter thrombosis and catheter-related infection.
Hemodialysis Unit Catheter Group
Adult patients who underwent temporary hemodialysis catheter insertion in the nephrology hemodialysis unit. Participants were followed for 10 days after catheter insertion to assess the development of catheter thrombosis and catheter-related infection.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidence of Catheter-Related Infection
Lasso di tempo: Within 10 days after hemodialysis catheter insertion
The incidence of catheter-related infection will be assessed in adult patients who underwent temporary hemodialysis catheter insertion in either the emergency department or the hemodialysis unit. Catheter-related infection will be recorded based on clinical evaluation, laboratory findings when available, and hospital records during the 10-day follow-up period after catheter insertion.
Within 10 days after hemodialysis catheter insertion
Incidence of Catheter Thrombosis
Lasso di tempo: Within 10 days after hemodialysis catheter insertion
The incidence of catheter thrombosis will be assessed in adult patients who underwent temporary hemodialysis catheter insertion in either the emergency department or the hemodialysis unit. Catheter thrombosis will be recorded based on clinical evaluation and hospital records during the 10-day follow-up period after catheter insertion.
Within 10 days after hemodialysis catheter insertion

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: MEHMET AKCIMEN, University of Health Sciences, Antalya Training and Research Hospital
  • Cattedra di studio: MURAT DUYAN, University of Health Sciences, Antalya Training and Research Hospital

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 dicembre 2024

Completamento primario (Effettivo)

11 dicembre 2025

Completamento dello studio (Effettivo)

11 dicembre 2025

Date di iscrizione allo studio

Primo inviato

9 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

9 giugno 2026

Primo Inserito (Effettivo)

12 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared due to privacy and confidentiality restrictions. The data used in this study contain patient-level clinical information, and no specific consent for public or external sharing of individual participant data was obtained. Only aggregated and anonymized results may be reported in scientific publications.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi